Docusate sodium (also known as dioctyl sodium sulfosuccinate) is a stool softener and surfactant used to relieve constipation by promoting the mixing of water and lipids into the stool, thereby softening fecal matter and making bowel movements easier. It does not stimulate intestinal motility, making it suitable for mild constipation and postoperative or postpartum patients.
It is available in oral (capsules, syrup) and rectal (enemas) formulations, and is also used as a pharmaceutical excipient and emulsifier.
Indications include:
• Temporary relief of occasional constipation
• Stool softening in patients with hemorrhoids, surgery, or cardiac conditions where straining is to be avoided
• As a wetting agent in pharmaceutical and industrial applications
Parent: Docusate Sodium
Parent: Docusate sodium
Parent: Docusate / Docusate Sodium
Impurities in docusate sodium arise from its synthesis via esterification and sulfonation of succinic acid derivatives, and from degradation, particularly in aqueous and high-temperature environments. As it is used in oral and rectal dosage forms, impurity control must comply with ICH Q3A/B, USP/NF, and FDA standards.
Process-Related Impurities
• Unreacted dioctyl alcohols or succinic acid derivatives
• By-products from sulfonation reactions
• Residual solvents such as isopropanol, acetone, or toluene
Degradation Impurities
• Hydrolysis to dioctyl alcohol and sodium sulfosuccinate salts under heat or acidic conditions
• Oxidation products of the alkyl side chains
• Impurities formed under extreme pH or prolonged storage
Elemental Impurities
• Trace metals like iron, zinc, or copper from manufacturing vessels
• Must comply with ICH Q3D limits for oral and rectal exposure
Analytical Techniques for Impurity Detection
• High-Performance Liquid Chromatography (HPLC) – for related substance analysis
• Gas Chromatography (GC) – for detecting and quantifying residual solvents
• LC-MS (Liquid Chromatography–Mass Spectrometry) – for degradation product identification
• ICP-MS – for elemental impurities
• Titrimetric and FT-IR methods – for identity and content determination
It is used to soften stools in cases of occasional constipation and to prevent straining in postoperative, cardiac, or hemorrhoidal patients.
It acts as a surfactant, allowing water and fats to penetrate and mix with stool, making it easier to pass.
• Mild abdominal cramps
• Diarrhea
• Bitter aftertaste (in oral solutions)
• Rare: Rash or throat irritation (in hypersensitive individuals)
No. It is a non-stimulant laxative and does not cause dependency when used as directed.
It is generally stable under standard conditions but may hydrolyze in aqueous or acidic environments. It should be stored in a cool, dry place, protected from heat and light.
